576 related articles for article (PubMed ID: 23689138)
1. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
[TBL] [Abstract][Full Text] [Related]
2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
3. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
4. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
6. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Zheng H; Li LL; Hu DS; Deng XY; Cao Y
Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
[TBL] [Abstract][Full Text] [Related]
7. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
9. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
11. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
[TBL] [Abstract][Full Text] [Related]
13. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma.
Morris MA; Dawson CW; Young LS
Future Oncol; 2009 Aug; 5(6):811-25. PubMed ID: 19663731
[TBL] [Abstract][Full Text] [Related]
14. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
16. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
17. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).
Dawson CW; Port RJ; Young LS
Semin Cancer Biol; 2012 Apr; 22(2):144-53. PubMed ID: 22249143
[TBL] [Abstract][Full Text] [Related]
18. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.
Horikawa T; Yoshizaki T; Kondo S; Furukawa M; Kaizaki Y; Pagano JS
Br J Cancer; 2011 Mar; 104(7):1160-7. PubMed ID: 21386845
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of TW01 cells expressing latent membrane protein-1 gene of EBV-derived from nasopharyngeal carcinoma cells at different stages of malignancy.
Tan EL; Sam CK
Exp Oncol; 2007 Sep; 29(3):166-74. PubMed ID: 18004239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]